The First IND CMC Playbook for Emerging Biotech is a practical guide for founders, CEOs, and biotech leaders who need to move a promising molecule toward an IND without losing time, capital, or momentum. Written for decision-makers who may not be CMC specialists, the book explains the business-critical choices that shape IND readiness, including development timing, CDMO strategy, analytical planning, stability, documentation, and phase-appropriate quality controls.
Built around the realities of small molecules, synthetic peptides, and synthetic oligonucleotides, this book translates complex CMC and regulatory issues into clear, actionable guidance. It gives readers enough technical depth to be useful to regulatory and CMC teams, while keeping the focus on the questions that matter most to founders: What must be committed now, what can still evolve, and where is the hidden risk that could delay the next milestone?
外文書商品之書封，為出版社提供之樣本。實際出貨商品，以出版社所提供之現有版本為主。部份書籍，因出版社供應狀況特殊，匯率將依實際狀況做調整。
無庫存之商品，在您完成訂單程序之後，將以空運的方式為你下單調貨。為了縮短等待的時間，建議您將外文書與其他商品分開下單，以獲得最快的取貨速度，平均調貨時間為1~2個月。
為了保護您的權益，「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨，請在商品鑑賞期內寄回，且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。
